Riber (ALRIB) Q3 2024 TU earnings summary

Executive summary

• Revenues for the nine months ended September 2024 increased by 14% year-over-year to €18.5m, reflecting solid business growth and a strengthened market position in molecular beam epitaxy equipment.

• The order book at September 30, 2024, rose 14% year-over-year to €38.3m, indicating robust demand and future revenue visibility.

Financial highlights

• First quarter revenues grew 20% year-over-year to €4.5m; second quarter up 10% to €9.3m; third quarter up 19% to €4.7m.

• Systems segment revenues increased 28% year-over-year to €12.3m, while services and accessories declined 6% to €6.2m.

• Geographical revenue split: Asia 68%, Europe 25%, North America 6%.

Outlook and guidance

• Full-year 2024 revenues are expected to exceed €40m, with further improvements in earnings anticipated.

• Continued growth in the compound semiconductor market is expected to drive new orders before year-end.